SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-22-003510
Filing Date
2022-05-10
Accepted
2022-05-10 15:54:07
Documents
47
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xbit20220331_10q.htm   iXBRL 10-Q 553745
2 EXHIBIT 31.1 ex_369917.htm EX-31.1 10606
3 EXHIBIT 31.2 ex_369918.htm EX-31.2 10665
4 EXHIBIT 32.1 ex_369919.htm EX-32.1 7801
  Complete submission text file 0001171843-22-003510.txt   3041181

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA xbit-20220331.xsd EX-101.SCH 26940
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE xbit-20220331_cal.xml EX-101.CAL 25875
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xbit-20220331_def.xml EX-101.DEF 211526
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE xbit-20220331_lab.xml EX-101.LAB 190184
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xbit-20220331_pre.xml EX-101.PRE 228778
41 EXTRACTED XBRL INSTANCE DOCUMENT xbit20220331_10q_htm.xml XML 357719
Mailing Address 5217 WINNEBAGO LANE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 5217 WINNEBAGO LANE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2900
XBiotech Inc. (Filer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37347 | Film No.: 22909351
SIC: 2834 Pharmaceutical Preparations